Specifically, in the case of bladder cancer, the use of BQR@MLipo has been shown to effectively target and inhibit DHODH activity, leading to mitochondrial lipid peroxidation and subsequent induction of ferroptosis in bladder cancer cells. The gene discussed is DHODH; the disease is urinary bladder carcinoma.